Xilong Scientific Co., Ltd. (002584.SZ)
CNY 7.65
(-0.52%)
CNY 7.65
(-0.52%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -284.71 Million | -190.88 Million | 346.61 Million | 44.57 Million | 95.89 Million | -97.1 Million |
| Net Income | 34.59 Million | 86.67 Million | 217.93 Million | 63.68 Million | 34.81 Million | 63.26 Million |
| Depreciation & Amortization | 49.29 Million | 44.46 Million | 34.77 Million | 29.89 Million | 36.65 Million | 36.16 Million |
| Deferred income taxes | -168.05 Thousand | 1.73 Million | -1.4 Million | 1.24 Million | 1.33 Million | -5.15 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -474.57 Million | -345.45 Million | 116.12 Million | -104.79 Million | -55.66 Million | -272.84 Million |
| Other non-cash items | 76.97 Million | 23.43 Million | -22.21 Million | 55.77 Million | 80.08 Million | 76.31 Million |
| Investing Cash Flow | 139.53 Million | -324.64 Million | 20.92 Million | 139.45 Million | 27.45 Million | -289.36 Million |
| Investments in PPE | -215.24 Million | -323.7 Million | -56.72 Million | -38.24 Million | -9.8 Million | -15.99 Million |
| Acquisitions | 6.51 Million | 384.94 Million | 118.98 Million | 187.7 Million | 16.25 Million | -407.84 Million |
| Investment purchases | -120.5 Million | -455.69 Million | -243.87 Million | -294.05 Million | -16.25 Million | -270.05 Million |
| Sales/Maturities of investments | 468.76 Million | 67.58 Million | 198.22 Million | 322.28 Million | 51 Thousand | 392.88 Million |
| Other Investing Activities | 354.77 Million | 2.22 Million | 4.32 Million | -38.24 Million | 37.21 Million | 11.64 Million |
| Financing Cash Flow | -30.12 Million | 334.53 Million | -341.54 Million | -533.38 Million | 82.19 Million | 753.32 Million |
| Debt repayment | -120.68 Million | -837.95 Million | -979.65 Million | -1.48 Billion | -979.9 Million | -540.49 Million |
| Dividends payments | -11.7 Million | -43.52 Million | -51.66 Million | -63.95 Million | -64.26 Million | -50.56 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -99.85 Million | 1.21 Billion | 689.77 Million | 1.01 Billion | 1.12 Billion | 1.34 Billion |
| Accounts receivables | -105.93 Million | -492.11 Million | -73.94 Million | 1.18 Billion | -405.77 Million | -303.17 Million |
| Accounts payables | -319.33 Million | 259.45 Million | -9.45 Million | -965.05 Million | 379.48 Million | 43.22 Million |
| Inventory | -49.13 Million | -114.52 Million | 236.07 Million | -328.96 Million | -30.7 Million | -7.73 Million |
| Other working capital | 4.01 Million | 1.73 Million | -36.56 Million | 1.24 Million | 1.33 Million | -265.1 Million |
| Cash at beginning of period | 330.22 Million | 520.26 Million | 492.65 Million | 822.54 Million | 621.24 Million | 254.95 Million |
| Cash at end of period | 150.6 Million | 330.22 Million | 520.26 Million | 492.65 Million | 822.54 Million | 621.24 Million |
| Capital Expenditure | -215.24 Million | -323.7 Million | -56.72 Million | -38.24 Million | -9.8 Million | -15.99 Million |
| Effect of forex changes on cash | -4.31 Million | -9.03 Million | 1.6 Million | 19.47 Million | -4.24 Million | -562.21 Thousand |
| Net cash flow / Change in cash | -179.62 Million | -190.03 Million | 27.61 Million | -329.89 Million | 201.29 Million | 366.28 Million |
| Free Cash Flow | -499.96 Million | -514.59 Million | 289.89 Million | 6.32 Million | 86.08 Million | -113.1 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 21.47 Million | 35.66 Million | 7.04 Million | 3.85 Million | 34.59 Million | 16.94 Million |
| Depreciation & Amortization | - | 18.78 Million | 18.78 Million | 14.58 Million | 49.29 Million | -19.55 Million |
| Deferred income taxes | - | - | - | - | -168.05 Thousand | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -140.68 Million | - | -151.04 Million | -474.57 Million | 248.33 Million |
| Other non-cash items | -6.88 Million | -7.07 Million | -2 Million | -22.7 Million | 76.97 Million | -199.68 Million |
| Investing Cash Flow | -11.64 Million | -27.46 Million | -67.16 Million | -10.86 Million | 139.53 Million | 44.96 Million |
| Investments in PPE | -11.53 Million | -29.03 Million | -3.06 Million | -14.51 Million | -215.24 Million | 213.57 Thousand |
| Acquisitions | 95.73 Thousand | 862.52 Thousand | -400 Thousand | -1.12 Million | 6.51 Million | 629.72 Thousand |
| Investment purchases | -200 Thousand | -400 Thousand | -63.7 Million | -120.1 Million | -120.5 Million | -629.72 Thousand |
| Sales/Maturities of investments | - | 1.1 Million | - | 124.87 Million | 468.76 Million | 44.12 Million |
| Other Investing Activities | - | 1.17 Million | -63.7 Million | 3.65 Million | 354.77 Million | 629.72 Thousand |
| Financing Cash Flow | -118.29 Million | 65.62 Million | 36.75 Million | 64.36 Million | -30.12 Million | -162.58 Million |
| Debt repayment | -60.39 Million | -22.63 Million | -16.3 Million | -20.31 Million | -120.68 Million | -301.65 Million |
| Dividends payments | - | -24.8 Million | -1.78 Million | -11.7 Million | -11.7 Million | -20.36 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -57.9 Million | 110.3 Million | 22.24 Million | 77.37 Million | -99.85 Million | 159.43 Million |
| Accounts receivables | - | -38.73 Million | - | -105.93 Million | -105.93 Million | 160.2 Million |
| Accounts payables | - | - | - | - | -319.33 Million | -2.37 Million |
| Inventory | - | -99.07 Million | - | -49.13 Million | -49.13 Million | 88.12 Million |
| Other working capital | - | -2.87 Million | - | 4.01 Million | 4.01 Million | 2.37 Million |
| Cash at beginning of period | 530.25 Million | 474.04 Million | 150.6 Million | 135.47 Million | 330.22 Million | 206.42 Million |
| Cash at end of period | 482.76 Million | 530.25 Million | 125.43 Million | 150.6 Million | 150.6 Million | 135.47 Million |
| Capital Expenditure | -11.53 Million | -29.03 Million | -3.06 Million | -14.51 Million | -215.24 Million | 213.57 Thousand |
| Effect of forex changes on cash | - | -183.57 Thousand | 194.67 Thousand | -5.06 Million | -4.31 Million | 639.03 Thousand |
| Net cash flow / Change in cash | -47.48 Million | 56.2 Million | -25.17 Million | 15.12 Million | -179.62 Million | -70.94 Million |
| Free Cash Flow | 3.05 Million | -19.24 Million | 1.97 Million | -47.95 Million | -499.96 Million | 46.24 Million |
2481
1803
CLGN
1303
LUCE
ASAZY